XTX Topco Ltd bought a new position in KORU Medical Systems, Inc. (NASDAQ:KRMD – Free Report) during the third quarter, Holdings Channel reports. The fund bought 12,602 shares of the company’s stock, valued at approximately $34,000.
Several other institutional investors also recently modified their holdings of the business. Meros Investment Management LP boosted its stake in KORU Medical Systems by 20.7% during the second quarter. Meros Investment Management LP now owns 804,380 shares of the company’s stock worth $2,132,000 after acquiring an additional 137,918 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. boosted its position in shares of KORU Medical Systems by 77.7% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 61,412 shares of the company’s stock worth $168,000 after purchasing an additional 26,860 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of KORU Medical Systems in the 2nd quarter worth approximately $107,000. Legato Capital Management LLC bought a new position in KORU Medical Systems during the 2nd quarter valued at approximately $35,000. Finally, Allspring Global Investments Holdings LLC purchased a new position in KORU Medical Systems during the second quarter valued at $28,000. 58.60% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
A number of research firms have recently commented on KRMD. Piper Sandler increased their target price on KORU Medical Systems from $3.00 to $3.50 and gave the stock an “overweight” rating in a research note on Thursday, November 14th. Canaccord Genuity Group raised their price objective on shares of KORU Medical Systems from $3.00 to $4.00 and gave the company a “buy” rating in a research note on Thursday, November 14th. Finally, Craig Hallum upped their target price on shares of KORU Medical Systems from $4.00 to $5.00 and gave the stock a “buy” rating in a research note on Thursday, November 14th.
KORU Medical Systems Price Performance
NASDAQ KRMD opened at $4.02 on Monday. KORU Medical Systems, Inc. has a one year low of $1.98 and a one year high of $4.60. The stock has a 50-day moving average of $3.30 and a 200 day moving average of $2.76. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.37 and a current ratio of 2.99. The company has a market capitalization of $184.26 million, a price-to-earnings ratio of -16.08 and a beta of 0.48.
About KORU Medical Systems
KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.
Featured Articles
- Five stocks we like better than KORU Medical Systems
- EV Stocks and How to Profit from Them
- XPO Stock Gains Momentum as U.S. Trade Outlook Evolves
- Options Trading – Understanding Strike Price
- CarMax Gets in Gear: Is Now the Time to Buy?
- What is a Secondary Public Offering? What Investors Need to Know
- Qubit Combat: 2 Stocks Battle for Quantum Supremacy
Want to see what other hedge funds are holding KRMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for KORU Medical Systems, Inc. (NASDAQ:KRMD – Free Report).
Receive News & Ratings for KORU Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KORU Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.